You can scan the QR code or go to the official website to check the authenticity of Renhe Pharmaceutical’s trademarks.

Renhe Pharmaceutical Co., Ltd. is a listed company listed on the Shenzhen Stock Exchange. The company’s stock code is: 000650. The company’s predecessor was Jiujiang Chemical Fiber Co., Ltd., which was approved by the Jiangxi Provincial People’s Government in 1996. , on November 18, 1996, approved by the China Securities Regulatory Commission Zhengjianfazi (1996) No. 318, the company was officially listed on the Shenzhen Stock Exchange.

The company's main business is the production and sales of Chinese and Western medicines and health-related products, including capsules, granules, tablets, suppositories, ointments, liniments and other medicines and health-related products. The company's main products: Renhe Kelik, Eucatan, Fuyanjie, Qinghuo Capsules, etc.

Major Events

On August 23, 2010, Jiangxi Renhe Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Renhe Pharmaceutical Co., Ltd., planned to invest 28.56 million yuan to acquire Jiangxi Renxiang Pharmaceutical Co., Ltd. Four natural persons of the company, Xu Chagen, Li Lin, Nie Wangen and Liu Runhui, hold 51% of the shares of Renxiang Pharmaceutical. After the acquisition is completed, Renxiang Pharmaceutical will become Sun Company.

In July 2021, Renhe Pharmaceutical announced that it planned to acquire 80% of the equity of seven companies including Shenzhen Sanpu Natural Cosmetics Co., Ltd. for 720 million yuan.

The above content refers to Baidu Encyclopedia - Renhe Pharmaceutical